BILLEV PHARMA ApS: Financial statements 2022
CVR: 81814813
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 30,170,800 and a net result of DKK 6,013,157 compared with DKK 5,548,863 the year before. That is an increase of 17.7% compared with the year before. Equity in the 2022 report amounted to DKK 6,333,157. The solvency ratio was 61.1%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 30,170,800
- Profit/Loss
- DKK 6,013,157
- Equity
- DKK 6,333,157
- Total Assets
- DKK 10,361,535
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 30.2 mio. | 6 mio. | 6.3 mio. | 21 |
| 2021 | - | 25.6 mio. | 5.5 mio. | 5.9 mio. | 19 |
| 2020 | - | 21.4 mio. | 3.8 mio. | 4.1 mio. | 16 |
| 2019 | - | 17.5 mio. | 2.5 mio. | 2.8 mio. | 14 |
| 2018 | - | 17.1 mio. | 3.7 mio. | 4 mio. | 13 |
Official annual report
Keep an eye on BILLEV PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Wencke van Arkens and Ulrikke Lynge Jensen. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.